海外の治験の状況「前立腺癌」での検索結果
266件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Greece, Hungary, India, Ireland, Italy, Korea, Republic of, Mexico, Norway, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2008-08-29
Not recruiting
- PROFIT - Prostate Fractionated Irradiation Trial
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Canada, France
- 2006-03-17
Not recruiting
- ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Belgium, Canada, Denmark, Finland, France, Indonesia, Netherlands, Norway, Poland, Sweden, Switzerland, United Kingdom, United States
- 2004-08-25
Not Recruiting
- Measurement of variation in imaging report findings for 68Ga-PSMA-11 PET/CT in patients with prostate cancer: an international study with participation of multiple centers
- Prostate cancer br>Cancer
- Australia, Austria, Denmark, France, Germany, Japan, United States of America
- 2016-10-27
Not recruiting
- A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
- Prostate Cancer Metastatic
- Australia, Belgium, Canada, Denmark, Estonia, France, Germany, Iceland, Israel, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2011-03-23
Not recruiting
- 18-Fluoride (18F) labelled Sodium Fluoride (NaF)) Positron Emission Tomography (PET)/Computer Tomography (CT); the impact on pre-operative staging of intermediate and high risk prostate cancer
- Prostate Cancer
- Australia
- 2014-08-19
Not Recruiting
- AFFIRM: A Multinational Phase 3, Randomized, Double-Blind, Placebo-COntrolled Efficacy and Safety Study of Oral MDV3100 in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
- Castration-Resistant Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Canada, Chile, France, Germany, Italy, Netherlands, Poland, South Africa, Spain, United Kingdom, United States
- 2014-04-14
Not recruiting
- RCT to evaluate effectiveness of telephone, mail or email approaches to collecting Patient Reported Outcome Measures (PROMs) data using Prostate Cancer Outcomes Registry-Victoria (PCOR-VIC)
- Prostate Cancer;Urinary function;Bowel function;Sexual function
- Australia
- 2015-12-16
Not recruiting
- Radionuclide therapy using Lutetium-177 prostate specific membrane antigen (PSMA): a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)
- Prostate Cancer
- Australia
- 2015-09-02
Not Recruiting
- A Three Arm Randomized, Open-label Phase II Study of Radium-223 Dichloride 50 kBq/kg (55 kBq/kg After Implementation of NIST Update) Versus 80 kBq/kg (88 kBq/kg After Implementation of NIST Update), and Versus 50 kBq/kg (55 kBq/kg After Implementation of NIST Update) in an Extended Dosing Schedule in Subjects With Castration-resistant Prostate Cancer Metastatic to the Bone
- Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Australia, Brazil, Canada, Chile, Czech Republic, Finland, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States
- 2015-06-25